Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Murali Ramachandran Insider Profile
4 Followers
Murali Ramachandran, VP of Research and Development at Kairos Pharma, Ltd., holds 133.06K shares in Kairos Pharma, Ltd. (Ticker: KAPA). Most recently, Murali Ramachandran Bought $200 shares of Kairos Pharma, Ltd. on Nov 25, 2024 for an estimated value of 318.00.
Murali Ramachandran has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Murali Ramachandran's holdings
Insider Roles
VP of Research and Development
Roles that Murali Ramachandran holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Murali Ramachandran
Murali Ramachandran's Trading History
List of latest transactions for each holding click on a transaction to see Murali Ramachandran's performance on stock
You May Also Like
Murali Ramachandran insider profile FAQ
What is the percentage of profitable transactions made by Murali Ramachandran?
The percentage of profitable transactions made by Murali Ramachandran is ―.
What is the average return per transaction made by Murali Ramachandran?
The average return per transaction made by Murali Ramachandran is ―.
What stocks does Murali Ramachandran hold?
Murali Ramachandran holds: KAPA stocks.
What was Murali Ramachandran’s latest transaction?
Murali Ramachandran latest transaction was an Informative Buy of $318.00.
What was Murali Ramachandran's most profitable transaction?
Murali Ramachandran’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Murali Ramachandran's role in Kairos Pharma, Ltd.?
Murali Ramachandran's role in Kairos Pharma, Ltd. is VP of Research and Development.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.